Clinical experience with 111 thoratec ventricular assist devices
The Annals of Thoracic SurgeryPublished 1 May 1999Open access
Lawrence R. McBride, Keith S. Naunheim, Andrew C. Fiore, Debbie A Moroney, Marc T. Swartz
Citations149
SJR quartileQ1
SJR score1.23
SNIP1.38
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Despite advances, VAD support remains associated with significant morbidity and operative mortality in patients with the Thoratec VAD.
Abstract
Despite advances, VAD support remains associated with significant morbidity and operative mortality.
Keywords
MedicineEngineering
Journal of Thoracic and Cardiovascular SurgeryOne hundred patients with the HeartMate left ventricular assist device: evolving concepts and technology
253 Citations1998Patrick M. McCarthy, Nicholas O. Smedira +5 more
The HeartMate device provided excellent hemodynamic support with low device-related thromboembolic events and infection and reliability of the device contributed to the high cost of therapy.
New England Journal of MedicineHeterotopic Prosthetic Ventricles as a Bridge to Cardiac Transplantation
157 Citations1988David J. Farrar, James Hill +9 more
It is concluded that heterotopic placement of prosthetic ventricles as a bridge to transplantation provides an effective method of temporarily supporting cardiac function in critically ill patients without removing the natural heart.
PubMedThe influence of infection on survival and successful transplantation in patients with left ventricular assist devices.
151 Citations1997Michael Argenziano, Catanese Ka +8 more
Infections are common in patients undergoing LVAD support, but they do not adversely affect survival, the rate of successful transplantation, or the incidence of posttransplantation infection.
Journal of Thoracic and Cardiovascular SurgeryEight years' experience with bridging to cardiac transplantation
130 Citations1994D. Glenn Pennington, Lawrence R. McBride +3 more
Data demonstrate the short- and long-term efficacy of bridging to transplantation with circulatory support devices and ensure that donor organs are not being "wasted" on the sickest patients.
PubMedPreoperative predictors of survival in patients with Thoratec ventricular assist devices as a bridge to heart transplantation. Thoratec Ventricular Assist Device Principal Investigators.
84 Citations1994Farrar Dj
To determine whether any preoperative predictors of survival exist, univariate statistics and multivariate stepwise logistic regression analysis were performed on pre-ventricular assist device demographics, hemodynamics, and blood chemistry in 186 patients receiving Thoratec ventricular assist devices while awaiting heart transplants.
The Annals of Thoracic SurgeryUse of the Pierce-Donachy ventricular assist device in patients with cardiogenic shock after cardiac operations
81 Citations1989D. Glenn Pennington, Lawrence R. McBride +8 more
Since 1981, 30 patients aged 15 to 71 years with profound cardiogenic shock refractory to conventional therapy after cardiotomy were supported with the Pierce-Donachy ventricular assist device and 47% survived.
Circulation ResearchIsolated ventricular systolic interaction during transient reductions in left ventricular pressure.
42 Citations1992John C. Woodard, E. Chow +1 more
TheVolume and pressure of one ventricle have been demonstrated to modulate the volume and pressure in the contralateral chamber during systole and diastole and resultant changes in RV flow and pressure development during these single unloaded beats may therefore be considered to result from pure systolic interaction.
ASAIO TransactionsEvaluation of Right Ventricular Function During Clinical Left Ventricular Assistance
36 Citations1989Robert L. Kormos, Thomas A. Gasior +6 more
The reduction of LV afterload produced by the left ventricular assist system (LVAS) results in RV afterload reduction, which permits even the marginal RV to function adequately during LVAS support.
The Annals of Thoracic SurgerySurgical techniques for the implantation of heterotopic prosthetic ventricles
22 Citations1989Brian L. Ganzel, Laman A. Gray +2 more
Several options exist for cannulation sites during the implantation of the heterotopic prosthetic ventricles and the indications, contraindications, advantages, disadvantages, and surgical technique for each option are described.
Surgical Clinics of North AmericaCARDIAC ASSIST DEVICES
20 Citations1998D. Glenn Pennington, Marc T. Swartz +2 more
Design and Evaluation of a Left Ventricular Assist Device: The Angle Port Pump
20 Citations1979James H. Donachy, D. L. Landis +4 more
A dedicated group of physicians, engineers, technical personnel, and veterinarians was established at The Pennsylvania State University in 1971 to develop a practical left ventricle-to-aortic assist device (LVAD) for use in patients with profound left ventricular failure.
The Annals of Thoracic SurgeryPanel 1 Patient selection
19 Citations1989D. Glenn Pennington, Lyle D. Joyce +2 more
The first panel for this morning is to deal with the important question of patient selection, and the criteria by which patients must be selected are the definition of cardiogenic shock and maximal inotropic support.
PubMedDevice related infections in patients supported with mechanical circulatory support devices for greater than 30 days.
18 Citations1992L R McBride, Marc T. Swartz +3 more
Mechanical circulatory support with systems that require transcutaneous cannulas or drive lines is associated with a high incidence of device related infections, but they do not preclude successful transplant, weaning, or survival.
PubMedOral anticoagulation in patients with ventricular assist devices.
8 Citations1991Szukalski Ea, Reedy Je +4 more
Nine men aged 25-63 years (mean 42 years) received pulsatile ventricular assist devices (VADs) as a bridge to cardiac transplantation and in 639 days of support, there was one thromboembolic event due to mechanical failure, and one pt.